1 and AMPK kinase comprise a protein kinase cascade that has been highly conserved throughout evolution (1, 2). Increases in AMP concentration ([AMP]) activate this cascade by four mechanisms (3-5). These mechanisms are as follows: 1) an allosteric activation by AMP of AMPK kinase, which then phosphorylates AMPK; 2) the binding of AMP to AMPK, which makes it a poorer substrate for protein phosphatases; 3) the binding of AMP to AMPK, which makes AMPK a better substrate for AMPK kinase; and 4) the allosteric activation by AMP of AMPK. The activating effects of AMP are antagonized by high concentrations of ATP. Since the AMPK is activated when AMP is elevated and ATP is depressed, AMPK is hypothesized to act as cellular "fuel gauge" (1).
left ventricle balloon measured the left ventricle pressure and heart rate. Hearts were electrically paced using a Grass stimulator (Grass, Quincy, MA). The catheter and balloon contained degassed 100 mM phenylphosphonic acid (PPA) as a phosphorous standard for 31 P NMR studies. All parameters were recorded with a MacLab system (AD Instruments, Mountain View, CA).
The experimental protocol was approved by the Harvard Medical Area Standing Committee on Animals and followed the recommendations of the National Institutes of Health and the American Physiological Society guidelines for the use and care of laboratory animals.
Metabolic Inhibitors-The BrO (Aldrich) was added to the KH perfusate. Perfusion with BrO for 25 min allows the irreversible inhibition of 3-ketothiolase and, therefore, the inhibition of ␤-oxidation of long chain fatty acids (16) . Inhibition of 3-ketothiolase restricts oxidation of fatty acids with at least six carbons. Fatty acids of four carbons, such as butyrate, are able to bypass the BrO inhibition, since thiolysis continues via acetoacetyl-thiolase, which is not inhibited by BrO (19) . Ten minutes of perfusion with 0.4 mM AOA, a reversible inhibitor of the malate-aspartate shuttle (17) , results in near complete inhibition of glucose oxidation (18) .
Experimental Protocols for Metabolic Inhibition and AMPK Activation-All hearts were paced at a heart rate of 300 bpm during the base-line period. First, two groups of hearts were perfused with KH for the 30-min base-line period (Glc group; n ϭ 6, NMR; n ϭ 6, AMPK/ ACC). Second, two groups of hearts were treated with 0.3 mM BrO, 0.4 mM AOA, and 4 mM butyric acid, a short chain fatty acid that bypasses the metabolic blocks, throughout the base-line period (GBA-Bu group; n ϭ 6, NMR; n ϭ 5, AMPK/ACC). Third, two groups of hearts were perfused with KH containing BrO during the base-line period (GB300 group; n ϭ 6, NMR; n ϭ 6, AMPK/ACC). Fourth, two groups of hearts were perfused with KH during the base-line period, followed by KH containing AOA throughout a 10-min period with a heart rate of 300 bpm (GA300 group; n ϭ 6, NMR; n ϭ 5, AMPK/ACC). Fifth, two groups of hearts were perfused with KH during the base-line period, followed by KH containing AOA throughout a 10-min period with a heart rate of 300 bpm followed by a 10-min period with a heart rate of 450 bpm (GA450 group; n ϭ 6, NMR; n ϭ 6, AMPK/ACC). Sixth, two groups of hearts were pretreated with BrO during the base-line period and perfused with KH containing AOA throughout the 10-min period with a heart rate of 300 bpm (GBA300 group; n ϭ 7, NMR; n ϭ 5, AMPK/ACC). Seventh, two groups were pretreated with BrO during the base-line period and perfused with KH containing AOA throughout a 10-min period with a heart rate of 300 bpm and subsequent 10-min period with a heart rate of 450 bpm (GBA450 group; n ϭ 7, NMR; n ϭ 6, AMPK/ ACC). At the end of the protocol, hearts for AMPK and ACC measurements were freeze-clamped with Wollenberger tongs cooled in liquid nitrogen and stored at Ϫ80°C until analysis.
P NMR Spectroscopy of Isolated Perfused Hearts-
31 P NMR free induction decays were acquired at 145.81 MHz using a Bruker AM-360 NMR spectrometer (Bruker Instruments, Inc., Billerica, MA) and at 161.94 MHz using a GE Omega NMR spectrometer (Bruker Instruments, Inc., Fremont, CA). Typically, 144 free induction decays were averaged using a 60-min pulse and a recycle time of 2.5 s over 6 min. The resonance areas and chemical shifts of the spectra were quantified using the NMR1 curve fitting program (Tripos Inc., St. Louis, MO). Saturation factors for resonances were determined from fully relaxed spectra, recycle time 15 s. Heart 31 P Metabolite Content and Calculation of AMP-The concentrations of the 31 P NMR-visible metabolites of hearts were derived as follows. Three 50-l aliquots of 100 mM PPA were introduced into the left ventricle balloon after the experimental protocol. One 31 P NMR spectrum was acquired following each addition of PPA. The total molar content of PPA in the increments, and the area of the PPA resonance were fit to the equation of a straight line by linear regression. The mean slope for the group was used to calculate molar content of the PCr, ATP, and P i , using the following equation. Concentrations were obtained as follows: first, dividing the content by the heart dry weight; second, converting to wet weight using a wet weight/dry weight ratio of 5.04; and third, dividing by the intracellular volume, estimated to be 0.4 ml/g wet weight of the heart.
The creatine kinase equilibrium expression was used to calculate cytosolic ADP from the equation (20),
where K eq is 1.66 ϫ 10
M
Ϫ1 . The creatine (Cr) content was estimated as the difference between the hearts PCr content measured by 31 P NMR and the total creatine content in the heart (21). The cytosolic AMP concentration was calculated using the adenylate kinase equilibrium,
where K eq is 1.05 (20) . Intracellular pH was calculated from the chemical shift of intracellular P i (d), relative to that of PCr (22) . pH ϭ 6.75 ϩ log ͑͑d Ϫ 3.27͒/͑5.69 Ϫ d͒͒ (Eq. 4)
Measurement of AMP-activated Protein Kinase Activity and AcetylCoA-carboxylase Activity-AMPK activity was measured using the method of Dagher et al. (23) with 200 mg of frozen tissue. AMPK activity was quantified as the incorporation of 32 P from [␥-32 P]ATP (10 GBq/mmol; PerkinElmer Life Sciences) into a synthetic peptide with the specific target sequence for AMPK, the SAMS peptide, amino acid sequence HMRSAMSGLHLVKRR (American Peptides, Sunnyvale, CA). The radioactivity was measured using a liquid scintillation counter (Tri-Carb 2100TR, Packard, IL). Protein content was determined with the Bradford method (24).
ACC activity was measured according to Inoue and Lowenstein (25) by the 14 CO 2 fixation from NaH 14 CO 3 (0.925 GBq/mmol; PerkinElmer Life Sciences) method performed in the presence of 20 mM citrate using a liquid scintillation counter.
Statistical Analysis-The data are presented as the mean and S.E. for each measurement. Statistical computations were performed with Statview (version 5.0.1; SAS Institute Inc., Cary, NC). An analysis of variance was used to compare measurements among the groups. A Fisher's protected least significant difference was used for comparison of the means. Differences were statistically significant if p was Ͻ0.05. GraphPad Prism (version 3.02 for Windows; GraphPad Software, San Diego, CA) was used for curve fitting. (Fig. 1 
RESULTS

P NMR-measured Metabolite Content of the Isolated Heart during the Protocol
31
P NMR spectra obtained from an isolated perfused rat heart during metabolic inhibition protocol. Perfusion conditions were as follows: top spectrum, Glc, KH containing glucose at a heart rate of 300 bpm; middle spectrum, GA300, KH containing glucose plus 0.4 mM AOA at a heart rate of 300 bpm; bottom spectrum, GA heart at a heart rate of 450 bpm GA450. 31 P NMR resonances were assigned as follows: PPA, the external standard in the left ventricular balloon; phosphomonoesters (PME); P i ; PCr; the ␥-phosphate resonance of ATP; the ␣-phosphate resonance of ATP; NAD ϩ and NADH; and the ␤-phosphate resonance of ATP. The [AMP] calculated for each spectrum is shown at the right.
[PCr] than hearts oxidizing glucose (26) . Because [ATP] varies little, the AMP/ATP follows a pattern similar to that for [AMP] .
AMP-activated Protein Kinase Activity (Table II , Fig. 2 )-AMPK activity measurements without the addition of AMP to the assay are labeled as w/o AMP in Table II and reflect the phosphorylation state of AMPK in vivo. These measurements provide a measure of the activation of the AMPK protein cascade in vivo. AMPK activity measured with 200 M AMP to the assay is labeled as w/ AMP in Table II . This represents the AMPK activity caused by both phosphorylation and allosteric activation.
The AMPK activity (without AMP) was equivalent in the in the Glc group and the GBA-Bu group, which was perfused with glucose, inhibitors, and butyrate (Table II) . The GA hearts paced at 450 bpm with restricted aerobic glucose oxidation exhibit increased AMPK activity. The AMPK activity (without AMP) for the GA450 group was greater than the Glc, GBA-Bu, GB300, and GA300 groups. GBA hearts with inhibited oxidation of fatty acids and glucose have increased AMPK activity by both measures.
The dependence of AMPK activity (without AMP) on the cytosolic [AMP] for the hearts in this study is shown in Fig. 2 . The relationship was fitted to the equation,
where v represents AMPK activity, A 0.5 is [AMP] at 50% AMPK activation, and V max is maximal activity. The parameters obtained from the fitting are as follows:
Computing the relationship between the AMPK activity and the AMP/ATP yields an A 0.5 of 0.210 ϫ10 Ϫ3 Ϯ 0.078 ϫ10 Ϫ3 . Acetyl-CoA-carboxylase Activity (Table II, Fig. 3 )-ACC activity for the GB300, GA450, and GBA450 groups was less than that of Glc hearts. To investigate the relationship between AMPK and ACC activities, the AMPK activity was plotted versus ACC activity for individual hearts. ACC activity negatively correlated with AMPK activity. The data were fit using linear regression to a line with a slope of Ϫ0.304 Ϯ 0.114.
DISCUSSION
Results in this paper define the relationship between AMPK activity and the cytosolic [AMP] in the isolated perfused rat heart. To our knowledge, this is the first correlation of AMPK activity with metabolically active cytosolic [AMP] in the isolated heart. To increase the cytosolic [AMP] in isolated perfused rat hearts, the heart's supply of acetyl-CoA was limited using the inhibitors bromo-octanoate and amino-oxyacetate. This method decreases both aerobic energy production and high energy phosphates, particularly PCr (18 (Fig. 2) . Maximal increases in AMPK activity have been reported by a number of investigators. In vitro measurements by Stein found a 300% maximal activity for the ␣1 AMPK isoform and a 1300% maximal activity for the ␣2 AMPK isoform (15) . The heart contains both AMPK isoforms with the ␣2 isoform accounting for 70 -80% of the total (27, 28) . Kudo et al. (29) reported a 200% increase in AMPK activity in the heart after 30 min of ischemia. A study by Marsin et al. (11) of AMPK activity during ischemia found a nearly 800% increase after 10 min of ischemia, which decreased to a 500% increase after 30 min of ischemia. In the present study, the maximal increase in AMPK activity observed was ϳ240% (relative to Glc, Table II) .
To investigate whether AMPK activity could be greater than the 240% that we observed in this study during ischemia, we measured AMPK activity (without AMP) after 30 min of ischemia. The AMPK activity, 107 pmol⅐min Ϫ1 ⅐g of protein Ϫ1 , is an increase of ϳ500% higher than the Glc group. Thus, the AMPK activity after 30 min of ischemia was approximately twice the maximal activity observed (ϳ240%) in the groups of this study. The greater AMPK activity observed in the ischemic heart could result from activation due to higher [AMP] . During noflow ischemia in the rat heart, [AMP] is higher for at least two reasons: first, [PCr] falls to nondetectable levels in about 10 min; second, pH i decreases to 6.3 within 10 min. Cytosolic AMP-specific 5Ј-nucleotidase, which deaminates AMP to adenosine and P i , is inhibited at a pH i of 6.3 (30) . Inhibition of 5Ј-nucleotidase allows AMP to accumulate to 143 M after 12 min of ischemia (30) . The conditions employed in the present study allow controlled increases in [AMP], but since 5Ј-nucleotidase is not inhibited, AMP does not accumulate. Hence, the AMPK activity achieved here may not be maximal.
[AMP] and AMPK Cascade-Using our methods to alter myocardial energy metabolism, the cytosolic [AMP] ranged from 0.2 to 28 M. The A 0.5 ϭ 1.8 M AMP suggests that the threshold for [AMP] activation of AMPK in the heart is low and that AMPK activity is maximal at [AMP] Ն 10 M. In vitro the relationship between AMPK activation and [AMP] for the ␣1 and ␣2 AMPK isoforms yields an A 0.5 equal to 5.7 Ϯ 2.0 and 16 Ϯ 3.5 M AMP, respectively (15) . Here, we measured total AMPK activity and, therefore, cannot distinguish the degree to which the individual isoforms are activated. The measurements of AMPK activity (without AMP) report the state activation of the AMPK cascade. Hardie et al. (14) developed a model of the AMPK cascade using an A 0.5 of 4 M AMP that predicts full activation below 10 M AMP. Our study, in accord with those of Hardie et al. (14) and Stein et al. (15) , found a hyperbolic relationship between AMPK activity and [AMP]. Marsin et al. report a linear correlation between AMPK activity in the AMP/ATP range of 0.03-1.31 in perfused rat hearts using total AMP and ATP measured by high pressure liquid chromatography (11) . Since most AMP is bound, however, the total AMP overestimates the cytosolic [AMP], which is presumably the allosteric regulator of the AMPK cascade activity. Our measurements of AMP/ATP are 100 -1000 times lower than those reported by Marsin (11) .
[ATP] and AMPK-ATP antagonizes the allosteric activation of AMPK by AMP because ATP competes with AMP for binding at the allosteric site but does not promote formation of the active conformation (5) . Because of this, Hardie and Carling have suggested that the kinase reacts to the AMP/ATP ratio (1). Using our methods to alter myocardial energy metabolism, the AMP/ATP ratio ranged from 0. [H ϩ ] and AMPK-Intracellular [H ϩ ] may alter AMPK activity. A study of AMPK in vitro found that progressive decreases of pH from 7.3 to 6.6 resulted in progressive increases in AMPK activity (31) . Manipulating energy metabolism in this study only modestly altered pH i . The GBA group hearts have a pH i of 7.0 when paced at 300 bpm and 6.9 when paced at 450 bpm, both of which are lower than the 7.1 of the Glc group. Thus, the alterations of AMPK activity observed in this study occurred at near normal pH i . Myocardial pH i typically decreases well below 7 during ischemia. If increased [H ϩ ] alters AMPK activity, this may contribute to the greater AMPK activity in the ischemic heart.
AMPK and ACC-AMPK activity plays a major role in the regulation, by phosphorylation, of ACC activity in the heart (28) and skeletal muscle (12) . ACC catalyzes the carboxylation of acetyl-CoA to form malonyl-CoA, which plays a pivotal role in the regulation of fatty acid metabolism. In heart and skeletal muscle, malonyl-CoA regulates carnitine palmitoyltransferase-1. Carnitine palmitoyltransferase-1 transfers long chain fatty acids from the cytosol into the mitochondrion, where the fatty acids are oxidized by ␤-oxidation. In the rat heart during reperfusion following ischemia, increased AMPK activity correlates with reduced ACC activity (32) . In this study, we also found a negative correlation between ACC activity and AMPK activity.
Conclusions-Our findings reveal important details of FIG. 3 . Correlation between AMPK activity and ACC activity. Measurements of ACC activity were plotted as a function of AMPK (without AMP) activity for individual hearts of the seven groups: Glc, GBA-Bu, GB300, GA300, GA450, GBA300, and GBA450. The linear regression line (solid line) fit to the data is shown along with the 95% confidence interval (dotted line). The regression line equation is as follows: y ϭ 52.2 Ϫ 0.304⅐x, where y represents ACC activity, x is AMPK activity; intercept ϭ 52.2 Ϯ 4.9; slope ϭ Ϫ0.304 Ϯ 0.114 (95% confidence interval Ϫ0.537 to Ϫ0.070); R 2 ϭ 0.208; p ϭ 0.013.
AMPK regulation in the heart. Because of its activation by AMP, AMPK is hypothesized to act as a "low fuel warning system" (1) or as a "master switch" for cellular energy levels (33) . For AMPK to function as a metabolic sensor, it must be activated rapidly and early during a metabolic stress if it is to help sustain energy levels. Our results indicate that the A 0.5 for activation of AMPK was 1.8 M. AMP concentrations in that range can result from PCr decreases of about 30% or less in the heart. These characteristics are consistent with AMPK functioning as a low fuel warning system. These results also indicate that AMPK activation could conceivably occur in situations other than ischemia. For example, Neubauer et al. (34) reported 30% decreases in the PCr/ATP ratio in the human heart during failure. The measures of PCr, ATP, and pH i by 31 P NMR provide the most accurate estimates of cytosolic [AMP] available. This enabled us to measure in the intact heart an A 0.5 of 1.8 M AMP, which is comparable with the A 0.5 measured in vitro in the presence of 0.2 mM ATP. In vitro, the AMPK A 0.5 increased 10 -20-fold at 4 mM ATP due to the antagonizing effect of ATP on the AMP activation of AMPK. In the present study, [ATP] was, however, always greater than 7 mM. The low A 0.5 in the presence of 7 mM [ATP] in the intact heart suggests several possible features of AMPK regulation in vivo: first, the ATP antagonism of AMPK activation is reduced; second, AMPK senses an [ATP] that is different than the average cytosolic concentration; or third, factors in addition to AMP activate AMPK in the heart. These possibilities remain to be explored.
